prism 5.0 jai instat 3.0 (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
prism 5.0 jai instat 3.0
Prism 5.0 Jai Instat 3.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+5%2E0+jai+instat+3%2E0/prism+5+0+jai+instat+3+0/pm20405247-76-11-16
Average 90 stars, based on 1 article reviews
Prism 5.0 Jai Instat 3.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+5%2E0+jai+instat+3%2E0/prism+5+0+jai+instat+3+0/pm20405247-76-11-16
Average 90 stars, based on 1 article reviews
prism 5.0 jai instat 3.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: c-erbB-2 and the "triple-state" in early breast carcinomas. Article Snippet: Although c-erbB-2 expression is, in general terms, an ominous prognostic indicator in breast carcinomas, there are suggestions that lack of this oncogene, when combined with analogous lack of estrogen (ER negative) and progesterone receptors (PgR negative)—‘‘triple-negative phenotype’’, is linked with an equally poor prognosis.. We investigated this hypothesis in a series of early ductal breast carcinomas.. A total of 116 specimens with early breast cancer, defined as tumors of B2 cm in size and clinically negative axilla, were studied immunohistochemically for ER, PgR, and c-erbB-2 expression. Article Title: The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Article Snippet: Breast carcinomas have been reported to contain a subpopulation of CD44?/CD24tumor cells with stem cell–like properties.. This study investigates the significance of these two molecules in connection with tumor aggression and prognosis.. The phenotypic profile of 139 breast carcinomas was investigated in paraffin sections using markers previously associated with stem cell–like properties (CD44, CD24), the ‘‘triple-state’’ (ER, PR, c-erb-B2), and angiogenesis (CD31). |